OTTAWA — The Government of Canada is investing $80 million over four years in precision oncology research as part of an effort to expand personalized cancer care across the country.

Health Minister Marjorie Michel announced the funding on September 24, 2026, with the investment going to the Terry Fox Research Institute (TFRI) and the next phase of the Marathon of Hope Cancer Centres Network.

Precision oncology uses the genetic and biological characteristics of cancer cells to help doctors develop more personalized approaches to treatment.

The second phase of the national network is expected to add 11,000 new cancer cases to its research program and strengthen systems for generating, analyzing and returning genomic information to support clinical care. The network will also expand participation to additional cancer institutions, including organizations in Canada's territories.

Health Canada said TFRI and participating institutions will match the federal investment, bringing the total funding to $160 million for precision oncology research through the network.

The initiative is aimed at strengthening collaboration among Canadian researchers, clinicians and institutions while improving access to advanced cancer research and personalized care.

The investment places genomic research and precision medicine at the centre of Canada's latest national cancer-care initiative.